{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:50Z","timestamp":1789726250772,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.tube.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T17:00:06Z","timestamp":1445619606000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["A review of the use of ethionamide and prothionamide in childhood tuberculosis"],"prefix":"10.1016","volume":"97","author":[{"given":"S.","family":"Thee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Garcia-Prats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Hesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tube.2015.09.007_bib1","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0041-3879(63)80115-4","article-title":"A\u00a0controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy","volume":"44","author":"Angel","year":"1963","journal-title":"Tubercle"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/AAC.45.3.810-814.2001","article-title":"Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids","volume":"45","author":"Auclair","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"4873","key":"10.1016\/j.tube.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/bmj.1.4873.1234","article-title":"Radio-iodine measurements of thyroid function during and after P.A.S. treatment of tuberculosis","volume":"1","author":"Balint","year":"1954","journal-title":"Br Med J"},{"issue":"5144","key":"10.1016\/j.tube.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"issue":"36","key":"10.1016\/j.tube.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"28326","DOI":"10.1074\/jbc.M003744200","article-title":"Activation of the pro-drug ethionamide is regulated in mycobacteria","volume":"275","author":"Baulard","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/endo.130.5.1315258","article-title":"Regulation of thyroid hormone synthesis in cultured ovine thyroid follicles","volume":"130","author":"Becks","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.tube.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02090905","volume":"132","author":"Bonicke","year":"1965","journal-title":"Beitr Klin Erforsch Tuberk Lungenkrankh"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0041-3879(68)90017-2","article-title":"A\u00a0comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association","volume":"49","author":"British Tuberculosis Association","year":"1968","journal-title":"Tubercle"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/AAC.01030-10","article-title":"Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis","volume":"55","author":"Brossier","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2015.09.007_bib11","first-page":"133","volume":"29","author":"Brouet","year":"1965","journal-title":"Rev Tuberc Pneumol"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib12","first-page":"6","article-title":"Observations on the antituberculous effectiveness of alpha-ethyl-thioisonicotinamide in tuberculosis in humans","volume":"79","author":"Brouet","year":"1959","journal-title":"Am Rev Tuberc"},{"issue":"13","key":"10.1016\/j.tube.2015.09.007_bib13","first-page":"522","article-title":"The binding of antituberculous drugs to normal and kwashiorkor serum","volume":"52","author":"Buchanan","year":"1977","journal-title":"South Afr Med J Suid-Afrik Tydskr Vir Geneeskde"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jac\/dku438","article-title":"Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study","volume":"70","author":"Cambau","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-3879(67)80039-4","article-title":"Severe hypoglycaemia in the course of treatment with streptomycin, isoniazid and ethionamide","volume":"48","author":"Cameron","year":"1967","journal-title":"Tubercle"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib16","first-page":"687","article-title":"Present aspects of bacterial resistance in tuberculosis","volume":"92","author":"Canetti","year":"1965","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0041-3879(68)90048-2","article-title":"Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials","volume":"49","year":"1968","journal-title":"Tubercle"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/AAC.44.5.1337-1341.2000","article-title":"Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations","volume":"44","author":"Conte","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.tube.2015.09.007_bib19","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.47.8.2442-2444.2003","article-title":"Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis","volume":"47","author":"Cynamon","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"e0116798","DOI":"10.1371\/journal.pone.0116798","article-title":"Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time","volume":"10","author":"Dalal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2015.09.007_bib21","first-page":"935","volume":"27","author":"De Voogd","year":"1963","journal-title":"Rev Tuberc Pneumol"},{"issue":"17","key":"10.1016\/j.tube.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1073\/pnas.97.17.9677","article-title":"Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis","volume":"97","author":"DeBarber","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2015.09.007_bib23","first-page":"126","volume":"10","author":"Devoogd","year":"1963","journal-title":"G\u00a0Ital Chemioter"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib24","first-page":"196","article-title":"Ethionamide-induced gynecomastia","volume":"3","author":"Dixit","year":"2012","journal-title":"J\u00a0Pharmacol Pharmacother"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","article-title":"Cerebrospinal fluid concentrations of antituberculosis agents in adults and children","volume":"90","author":"Donald","year":"2010","journal-title":"Tuberculosis"},{"issue":"7","key":"10.1016\/j.tube.2015.09.007_bib26","first-page":"741","article-title":"Hepatic toxicity during chemotherapy for severe tuberculosis meningitis","volume":"141","author":"Donald","year":"1987","journal-title":"Am J Dis Child"},{"issue":"9","key":"10.1016\/j.tube.2015.09.007_bib27","first-page":"704","article-title":"Intensive short course chemotherapy in the management of tuberculous meningitis","volume":"2","author":"Donald","year":"1998","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3476(89)80862-5","article-title":"Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis","volume":"115","author":"Donald","year":"1989","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib29","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jmb.2004.06.003","article-title":"Crystal structure of the TetR\/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance","volume":"340","author":"Dover","year":"2004","journal-title":"J\u00a0Mol Biol"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-100-6-837","article-title":"Ethionamide-induced goitrous hypothyroidism","volume":"100","author":"Drucker","year":"1984","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5588\/ijtld.11.0388","article-title":"Ethionamide-induced hypothyroidism","volume":"16","author":"Dutta","year":"2012","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"7157","key":"10.1016\/j.tube.2015.09.007_bib32","first-page":"964","article-title":"Ethionamide","volume":"2","year":"1960","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1472-9792(08)70009-X","article-title":"Ethionamide","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(12)70033-6","article-title":"Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Ettehad","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02090916","volume":"132","author":"Eule","year":"1965","journal-title":"Beitr Klin Erforsch Tuberk Lungenkrankh"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4269\/ajtmh.2006.74.457","article-title":"A\u00a0clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy","volume":"74","author":"Fajardo","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1021\/jm200825u","article-title":"Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors","volume":"55","author":"Flipo","year":"2012","journal-title":"J\u00a0Med Chem"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0041-3879(69)90019-1","article-title":"A\u00a0study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis","volume":"50","author":"Fox","year":"1969","journal-title":"Tubercle"},{"key":"10.1016\/j.tube.2015.09.007_bib39","first-page":"118","volume":"22","author":"Freour","year":"1965","journal-title":"Arch Francaises Pediatr"},{"key":"10.1016\/j.tube.2015.09.007_bib40","first-page":"209","volume":"12","author":"Freour","year":"1965","journal-title":"Ann Pediatr"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0378-6323.82405","article-title":"Ethionamide-induced pellagroid dermatitis resembling lichen simplex chronicus: a report of two cases","volume":"77","author":"Garg","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/AAC.05649-11","article-title":"Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis","volume":"56","author":"Grau","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0041-3879(82)80007-X","article-title":"The role of low dosage prothionamide with and without 4,4\u2032-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis","volume":"63","author":"Grosset","year":"1982","journal-title":"Tubercle"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib44","first-page":"411","volume":"17","author":"Grunert","year":"1967","journal-title":"Arzneim"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib45","first-page":"406","volume":"133","author":"Grunert","year":"1970","journal-title":"Z\u00a0Erkrank Atmungsorgane Folia Bronchol"},{"issue":"12","key":"10.1016\/j.tube.2015.09.007_bib46","first-page":"1250","volume":"30","author":"Guimard","year":"1966","journal-title":"Rev Tuberc Pneumol"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib47","first-page":"175","article-title":"Acceptability of thioamides. I. Ethionamide","volume":"23","author":"Gupta","year":"1977","journal-title":"J\u00a0Postgrad Med"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib48","first-page":"181","article-title":"Acceptability of thioamides. II. Prothionamide","volume":"23","author":"Gupta","year":"1977","journal-title":"J\u00a0Postgrad Med"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib49","first-page":"25","article-title":"A\u00a0comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients","volume":"68","author":"Gupta","year":"1977","journal-title":"J\u00a0Indian Med Assoc"},{"issue":"9","key":"10.1016\/j.tube.2015.09.007_bib50","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.5588\/ijtld.12.0305","article-title":"Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK","volume":"16","author":"Gupta","year":"2012","journal-title":"Int J Tuberc Lung Dis Off J Int Union against Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/380795","article-title":"Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis","volume":"38","author":"Gurumurthy","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jac\/dkl332","article-title":"Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria","volume":"58","author":"Hanoulle","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib53","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/ajrccm\/137.5.1217","article-title":"Qualitative and quantitative drug-susceptibility tests in mycobacteriology","volume":"137","author":"Heifets","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/ajrccm\/143.2.268","article-title":"Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis","volume":"143","author":"Heifets","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib55","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.taap.2008.09.017","article-title":"Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes","volume":"233","author":"Henderson","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.tube.2015.09.007_bib56","series-title":"Pharmacokinetics of second line TB therapy in children","author":"Hesseling","year":"2012"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib57","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-198409060-00003","article-title":"Clinical pharmacokinetics of the antituberculosis drugs","volume":"9","author":"Holdiness","year":"1984","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0007-0971(68)80006-3","article-title":"Acute hepatic necrosis associated with ethionamide","volume":"62","author":"Hollinrake","year":"1968","journal-title":"Br J Dis Chest"},{"issue":"7230","key":"10.1016\/j.tube.2015.09.007_bib59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0140-6736(62)91602-1","article-title":"Ethionamide: its passage into the cerebrospinal fluid in man","volume":"1","author":"Hughes","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2015.09.007_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0041-3879(60)80061-X","article-title":"Ethionamide (\u20181314\u2019) with streptomycin in acute tuberculosis of recent origin in Uganda Africans: a pilot study","volume":"41","author":"Hutton","year":"1960","journal-title":"Tubercle"},{"key":"10.1016\/j.tube.2015.09.007_bib61","series-title":"Trecator (ethionamide tablets, USP) tablets prescribing information","author":"Inc., W. P.","year":"2005"},{"key":"10.1016\/j.tube.2015.09.007_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0041-3879(61)80110-4","article-title":"An investigation of the value of ethionamide with pyrazinamide or cycloserine in the treatment of chronic pulmonary tuberculosis. A report from the Research Committee of the British Tuberculosis Association","volume":"42","year":"1961","journal-title":"Tubercle"},{"issue":"9","key":"10.1016\/j.tube.2015.09.007_bib63","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/jac\/dku161","article-title":"Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"69","author":"Jagielski","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/13.3.267","article-title":"A\u00a0comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man","volume":"13","author":"Jenner","year":"1984","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib65","first-page":"31","article-title":"Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages","volume":"58","author":"Jenner","year":"1987","journal-title":"Lepr Rev"},{"issue":"11","key":"10.1016\/j.tube.2015.09.007_bib66","first-page":"699","volume":"22","author":"Jentgens","year":"1968","journal-title":"Prax Pneumol Ver Tuberk"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2042-7158.1967.tb07986.x","article-title":"The metabolism of ethionamide and its sulphoxide","volume":"19","author":"Johnston","year":"1967","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib68","first-page":"195","volume":"135","author":"Kalich","year":"1971","journal-title":"Z\u00a0Erkrank Atmungsorgane Folia Bronchol"},{"key":"10.1016\/j.tube.2015.09.007_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0041-3879(65)80058-7","article-title":"Chemotherapy regimens used in retreatment of pulmonary tuberculosis. I. Observations on the efficacy of combinations of kanamycin, ethionamide and either cycloserine or pyrazinamide","volume":"46","author":"Kass","year":"1965","journal-title":"Tubercle"},{"issue":"11","key":"10.1016\/j.tube.2015.09.007_bib70","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1128\/AAC.37.11.2344","article-title":"Therapy of multidrug-resistant tuberculosis: lessons from studies with mice","volume":"37","author":"Klemens","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib71","first-page":"1053","article-title":"Psychotoxic reaction during ethionamide therapy","volume":"95","author":"Lansdown","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"10.1016\/j.tube.2015.09.007_bib72","first-page":"1161","article-title":"Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis","volume":"13","author":"Lee","year":"2009","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib73","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0007-0971(65)80054-7","article-title":"Ethionamide 1,000\u00a0mG. and isoniazid 400\u00a0mG. in previously untreated cases of pulmonary tuberculosis","volume":"59","author":"Lees","year":"1965","journal-title":"Br J Dis Chest"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib74","first-page":"966","article-title":"Ethionamide, 750\u00a0mg. daily, plus isoniazid, 450\u00a0mg. daily, in previously untreated cases of pulmonary tuberculosis","volume":"92","author":"Lees","year":"1965","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib75","first-page":"109","article-title":"Ethionamide, 500\u00a0mg. daily, plus isoniazid, 500\u00a0mg. or 300\u00a0mg. daily in previously untreated patients with pulmonary tuberculosis","volume":"95","author":"Lees","year":"1967","journal-title":"Am Rev Respir Dis"},{"issue":"8","key":"10.1016\/j.tube.2015.09.007_bib76","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/jac\/dkt090","article-title":"High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations","volume":"68","author":"Machado","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib77","first-page":"75","article-title":"Absorption of ethionamide and prothionamide in\u00a0vitro and in\u00a0vivo","volume":"57","author":"Mattila","year":"1968","journal-title":"Ann Med Intern Fenn"},{"issue":"26","key":"10.1016\/j.tube.2015.09.007_bib78","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1056\/NEJM200506303522621","article-title":"Hypothyroidism due to ethionamide","volume":"352","author":"McDonnell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tube.2015.09.007_bib79","series-title":"Momentum in the pediatric tuberculosis treatment pipeline","author":"McKenna","year":"2015"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib80","first-page":"376","article-title":"Drug resistance in tuberculosis","volume":"25","author":"Mitchison","year":"2005","journal-title":"Eur Respir J Off J Eur Soc Clin Respir Physiol"},{"issue":"11","key":"10.1016\/j.tube.2015.09.007_bib81","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.5588\/ijtld.12.0403","article-title":"Prevalence of hypothyroidism among MDR-TB patients in Botswana","volume":"16","author":"Modongo","year":"2012","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0974-777X.138506","article-title":"Anti tuberculosis drug resistance in west of Iran","volume":"6","author":"Mohajeri","year":"2014","journal-title":"J\u00a0Glob Infect Dis"},{"key":"10.1016\/j.tube.2015.09.007_bib83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/1471-2334-13-432","article-title":"Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania","volume":"13","author":"Mpagama","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib84","first-page":"344","article-title":"inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa?","volume":"15","author":"Muller","year":"2011","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0041-3879(72)90031-1","article-title":"Acute psychotic reaction probably caused by ethionamide","volume":"53","author":"Narang","year":"1972","journal-title":"Tubercle"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib86","first-page":"1","article-title":"Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy","volume":"52","author":"Pattyn","year":"1984","journal-title":"Int J Lepr Other Mycobact Dis Off Organ Int Lepr Assoc"},{"issue":"15","key":"10.1016\/j.tube.2015.09.007_bib87","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis","volume":"62","author":"Peloquin","year":"2002","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/j.1875-9114.1991.tb02645.x","article-title":"Pharmacokinetic evaluation of ethionamide suppositories","volume":"11","author":"Peloquin","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tube.2015.09.007_bib89","first-page":"896","article-title":"Ethionamide jaundice","volume":"87","author":"Phillips","year":"1963","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib90","first-page":"1152","article-title":"Ethionamide treatment and pregnancy","volume":"5","author":"Potworowska","year":"1966","journal-title":"Pol Med J"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002849900095","article-title":"In\u00a0vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages","volume":"33","author":"Rastogi","year":"1996","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.tube.2015.09.007_bib92","first-page":"116","volume":"122","author":"Rist","year":"1964","journal-title":"Z\u00a0Tuberk Erkrank Thoraxorg"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib93","first-page":"1","article-title":"Experiments on the antituberculous activity of alpha-ethylthioisonicotinamide","volume":"79","author":"Rist","year":"1959","journal-title":"Am Rev Tuberc"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib94","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JCM.44.3.688-692.2006","article-title":"Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials","volume":"44","author":"Rusch-Gerdes","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.tube.2015.09.007_bib95","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5588\/ijtld.13.0516","article-title":"Survey of tuberculosis drug resistance among Tibetan refugees in India","volume":"18","author":"Salvo","year":"2014","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib96","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5588\/ijtld.11.0615","article-title":"High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho","volume":"16","author":"Satti","year":"2012","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.tube.2015.09.007_bib97","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.tube.2015.09.007_bib98","doi-asserted-by":"crossref","first-page":"770","DOI":"10.5588\/ijtld.13.0069","article-title":"Trends in childhood drug-resistant tuberculosis in South Africa: a window into the wider epidemic?","volume":"18","author":"Schaaf","year":"2014","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10096-007-0257-9","article-title":"Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children","volume":"26","author":"Schaaf","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.5588\/ijtld.10.0238","article-title":"Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis","volume":"15","author":"Schon","year":"2011","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib101","first-page":"685","article-title":"Comparison of ethionamide with isoniazid in original treatment cases of pulmonary tuberculosis. XIV. A report of the Veterans Administration\u2013Armed Forces cooperative study","volume":"93","author":"Schwartz","year":"1966","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib102","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/thoraxjnl-2013-203900","article-title":"High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study","volume":"69","author":"Seddon","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.tube.2015.09.007_bib103","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/INF.0b013e318253acf8","article-title":"Impact of drug resistance on clinical outcome in children with tuberculous meningitis","volume":"31","author":"Seddon","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0041-3879(79)90019-9","article-title":"Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis","volume":"60","author":"Sharma","year":"1979","journal-title":"Tubercle"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib105","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4103\/0253-7613.100408","article-title":"Gynecomastia caused by ethionamide","volume":"44","author":"Sharma","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.tube.2015.09.007_bib106","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0041-3879(62)80003-8","article-title":"Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis","volume":"43","author":"Somner","year":"1962","journal-title":"Tubercle"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib107","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0041-3879(67)80008-4","article-title":"Changes in serum transaminase due to prothionamide","volume":"48","author":"Somner","year":"1967","journal-title":"Tubercle"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib108","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1086\/517171","article-title":"Hypothyroidism in a patient receiving treatment for multidrug-resistant tuberculosis","volume":"27","author":"Soumakis","year":"1998","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib109","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0041-3879(72)90030-X","article-title":"Reversible pellagra-like encephalopathy with ethionamide and cycloserine","volume":"53","author":"Swash","year":"1972","journal-title":"Tubercle"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/AAC.2.1.29","article-title":"Effect of isoniazid on the in\u00a0vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis","volume":"2","author":"Takayama","year":"1972","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.tube.2015.09.007_bib111","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1128\/AAC.00379-11","article-title":"Pharmacokinetics of ethionamide in children","volume":"55","author":"Thee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.tube.2015.09.007_bib112","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.5588\/ijtld.10.0707","article-title":"Abnormal thyroid function tests in children on ethionamide treatment","volume":"15","author":"Thee","year":"2011","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.tube.2015.09.007_bib113","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/089033449801400427","article-title":"The safety of antituberculosis medications during breastfeeding","volume":"14","author":"Tran","year":"1998","journal-title":"J\u00a0Hum Lact"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-3879(72)90046-3","article-title":"Permeability of tuberculous cavities to antituberculosis drugs","volume":"53","author":"Tsukamura","year":"1972","journal-title":"Tubercle"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5588\/ijtld.12.0511","article-title":"Can inhA mutation predict ethionamide resistance?","volume":"17","author":"Vadwai","year":"2013","journal-title":"Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1463423611000594","article-title":"Methods, strategies and technologies used to conduct a scoping literature review of collaboration between primary care and public health","volume":"13","author":"Valaitis","year":"2012","journal-title":"Prim Health Care Res Dev"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib117","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138920013804545151","article-title":"Metabolism of the antituberculosis drug ethionamide","volume":"14","author":"Vale","year":"2013","journal-title":"Curr Drug Metab"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib118","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/INF.0000000000000065","article-title":"Short intensified treatment in children with drug-susceptible tuberculous meningitis","volume":"33","author":"van Toorn","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib119","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1365-2958.2008.06365.x","article-title":"Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis","volume":"69","author":"Vilcheze","year":"2008","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2015.09.007_bib120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/AAC.49.2.708-720.2005","article-title":"Altered NADH\/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria","volume":"49","author":"Vilcheze","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2015.09.007_bib121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20062100","article-title":"Mechanism of thioamide drug action against tuberculosis and leprosy","volume":"204","author":"Wang","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.tube.2015.09.007_bib122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nm.1950","article-title":"Synthetic EthR inhibitors boost antituberculous activity of ethionamide","volume":"15","author":"Willand","year":"2009","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.tube.2015.09.007_bib123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1099\/00221287-66-3-379","article-title":"Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG","volume":"66","author":"Winder","year":"1971","journal-title":"J\u00a0Gen Microbiol"},{"key":"10.1016\/j.tube.2015.09.007_bib124","series-title":"Summary of outcomes from WHO Expert Group meeting on drug susceptibility testing-preliminary; 4th annual GLI meeting 17 April 2012","author":"World Health Organization, p. b. F. M","year":"2012"},{"issue":"2\u20133","key":"10.1016\/j.tube.2015.09.007_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1054\/tube.2002.0330","article-title":"Population pharmacokinetics of ethionamide in patients with tuberculosis","volume":"82","author":"Zhu","year":"2002","journal-title":"Tuberculosis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215300469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215300469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T23:25:33Z","timestamp":1718148333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215300469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":125,"alternative-id":["S1472979215300469"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2015.09.007","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the use of ethionamide and prothionamide in childhood tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}